dc.contributor.author | Andia, Irene | |
dc.contributor.author | Kaida, Angela | |
dc.contributor.author | Maier, Marissa | |
dc.contributor.author | Guzman, David | |
dc.contributor.author | Emenyonu, Nneka | |
dc.contributor.author | Pepper, Larry | |
dc.contributor.author | Bangsberg, David R. | |
dc.contributor.author | Hogg, Robert S. | |
dc.date.accessioned | 2023-10-31T09:25:06Z | |
dc.date.available | 2023-10-31T09:25:06Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Andia, I., Kaida, A., Maier, M., Guzman, D., Emenyonu, N., Pepper, L., ... & Hogg, R. S. (2009). Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda. Andia, I., Kaida, A., Maier, M., Guzman, D., Emenyonu, N., Pepper, L., ... & Hogg, R. S. (2009). Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda. American journal of public health, 99(2), 340-347., 99(2), 340-347. | en_US |
dc.identifier.uri | http://ir.must.ac.ug/xmlui/handle/123456789/3226 | |
dc.description.abstract | Objectives: We investigatedwhether the prevalence of contraceptive use among women who are HIV positive varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda.
Methods: We used data from a cross-sectional survey of 484 women who were HIV positive (18–50 years) and were attending Mbarara University’s HIV clinic, 45% of whom were receiving HAART.Multivariate logistic regression was used to investigate the association between HAART use and contraceptive use. Data were collected between November 2005 and June 2006.
Results: Overall, 45% of the women were sexually active in the previous 3 months. Of these, 85% reported using contraceptive methods, with 84% reporting use of barrier contraceptive methods. Women receiving HAART were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR]=2.64; 95% confidence interval [CI]=1.07, 6.49) and more than 3 times as likely to use barrier contraceptive methods (AOR=3.62; 95% CI=1.54, 8.55) than were women not receiving HAART.
Conclusions: Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV positive. (Am J Public Health. 2009; 99:340–347. doi:10.2105/AJPH.2007.129528) | en_US |
dc.description.sponsorship | National Institutes of Health (grant MH54907) and the University of California, San Francisco, Gladstone Institute of Virology
& Immunology Center for AIDS Research (grant P30 AI27763) | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Andia, I., Kaida, A., Maier, M., Guzman, D., Emenyonu, N., Pepper, L., ... & Hogg, R. S. (2009). Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda. American journal of public health, 99(2), 340-347. | en_US |
dc.subject | Antiretroviral Therapy | en_US |
dc.subject | HIV-Positive Women | en_US |
dc.subject | Uganda | en_US |
dc.subject | HAART | en_US |
dc.title | Highly Active Antiretroviral Therapy and Increased Use of Contraceptives Among HIV-Positive Women During Expanding Access to Antiretroviral Therapy in Mbarara, Uganda | en_US |
dc.type | Article | en_US |